Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:5-Acetylamino-6-amino-3-methyluracil)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003788 AN006224 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Meningitis Broad Institute of MIT and Harvard LC-MS
ST003788 AN006224 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Tuberculosis Broad Institute of MIT and Harvard LC-MS
ST003636 AN005969 Individual glycemic responses to carbohydrates vary and reflect underlying metabolic physiology (metabolomics) Blood Human Diabetes, Cardiovascular Disease Stanford University LC-MS
ST003636 AN005970 Individual glycemic responses to carbohydrates vary and reflect underlying metabolic physiology (metabolomics) Blood Human Diabetes, Cardiovascular Disease Stanford University LC-MS
ST003520 AN005781 Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis Blood Human Arthritis University of Kansas LC-MS
ST003356 AN005497 Noninvasive multiomic measurement of cell type repertoires in human urine Urine Human Urinary tract infection CZ Biohub LC-MS
ST003178 AN005220 Post-Infectious MECFS at the NIH Cerebrospinal fluid Human Chronic fatigue syndrome National Institutes of Health Other
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences LC-MS
ST003032 AN004972 Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens Urine Human National Center for Advancing Translational Sciences Other
ST003024 AN004958 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 Bacterial cells Pseudomonas aeruginosa Monash Institute of Pharmaceutical Sciences LC-MS
ST003002 AN004931 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) Feces Human Sarcopenia Chinese University of Hong Kong GC/LC-MS
ST002977 AN004887 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004888 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004889 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004890 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002968 AN004876 Untargeted metabolomic studies of the PSD95-nNOS uncoupling agent against post-stroke depression in rats Brain cortex Rat Depression Nanjing University of Science & Technology LC-MS
ST002909 AN004778 Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis Blood Human Melioidosis University of Washington Other
ST002903 AN004762 Identification and targeting of microbial putrescine acetylation in bloodstream infections Blood Human Septic shock Broad Institute of MIT and Harvard LC-MS
ST002820 AN004597 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center Other
ST002819 AN004593 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center Other
ST002818 AN004589 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center Other
ST002536 AN004171 Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma Thyroid Human Cancer Broad Institute of MIT and Harvard LC-MS
ST002498 AN004657 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine LC-MS
ST002471 AN004033 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002471 AN004035 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002470 AN004029 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002246 AN003666 Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study Feces Human Broad Institute of MIT and Harvard LC-MS
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham and Women's Hospital LC-MS
ST002089 AN003413 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health LC-MS
ST002088 AN003409 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health LC-MS
ST002075 AN003382 Profiling of the human intestinal microbiome and bile acids under physiologic conditions using an ingestible sampling device (Part 2) Intestine Human University of California, Davis LC-MS
ST002027 AN003297 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) Blood Human University of California, Davis LC-MS
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center LC-MS
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center LC-MS
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center LC-MS
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center LC-MS
ST002016 AN003284 Metabolomics of COVID patients Blood Human COVID-19 University of Virginia LC-MS
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001928 AN003136 Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype Urine Human George Mason University LC-MS
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai LC-MS
ST001749 AN002851 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin-Madison LC-MS
ST001680 AN002739 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine LC-MS
ST001639 AN002684 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health LC-MS
ST001521 AN002533 Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) Blood Human Broad Institute of MIT and Harvard LC-MS
ST001519 AN002525 Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) Feces Human Broad Institute of MIT and Harvard LC-MS
ST001515 AN002514 A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans Blood Human Obesity Translational Research Institute- AdventHealth Orlando LC-MS
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan LC-MS
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan LC-MS
ST001122 AN001847 Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part II) Urine Human Interstitial cystitis University of California, Davis LC-MS
ST001000 AN001878 Gut microbiome structure and metabolic activity in inflammatory bowel disease Feces Human Broad Institute of MIT and Harvard LC-MS
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000923 AN001513 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST000923 AN001514 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST000899 AN001465 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center LC-MS
ST000567 AN000871 Large Scale HILIC Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function Blood Human Heart disease Mayo Clinic LC-MS
ST000335 AN000541 Metabolomics of bovine uterine fluid at the onset of conceptus elongation Uterus Cow University of Florida LC-MS
ST000291 AN000464 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida LC-MS
  logo